Darcy Krueger
Director · Cincinnati Children's Hospital Medical Center
Credentials: · · · ·
History
Research
Pediatric Neurology · 2013 · 1,068 citations
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis
New England Journal of Medicine · 2010 · First of 10 authors · 757 citations
Pediatric Neurology · 2013 · First of 3 authors · Corresponding · 606 citations
- MS
56 papers
45 papers
41 papers
40 papers
32 papers
28 papers
26 papers
- PD
16 papers · 2 as a resident
Grants
- 2014–2030
Developmental Synaptopathies Associated with TSC, PTEN, SHANK3 and SynGAP1 Pathogenic Variants
National Institute of Neurological Disorders and Stroke · U54
Project lead · $2.5M · Boston Children's Hospital
- 2021–2027
Sirolimus TSC Epilepsy Prevention Study (STEPS) IND#145820 11/8/2019
Food and Drug Administration · R01
Contact PI · $3.9M · Cincinnati Childrens Hosp Med Ctr
- 2012–2019
Early Biomarkers of Autism Spectrum Disorders in Infants with Tuberous Sclerosis
National Institute of Neurological Disorders and Stroke · U01
PI · $13.3M · Boston Children's Hospital
Clinical trials
- 2021–2027
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Principal investigator · Recruiting · Phase 2
Darcy Krueger
- 2020–2022
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
Principal investigator · Completed · Phase 1, Phase 2
Children's Hospital Medical Center, Cincinnati
- 2013–2020
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Principal investigator · Completed
Boston Children's Hospital
- 2010–2016
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
Principal investigator · Completed · Phase 1, Phase 2
Children's Hospital Medical Center, Cincinnati